Defiance Daily Target 2X Long SMCI ETFの空売り状況は、投資家がDefiance Daily Target 2X Long SMCI ETFの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Defiance Daily Target 2X Long SMCI ETF (NASDAQ:SMCX), 空売り情報

The Fund is an actively managed exchange traded fund (ETF) that attempts to achieve two times (200 percent) the daily percentage change in the share price of the Underlying Security by entering into swap agreements on the Underlying Security. The Fund aims to achieve this daily percentage change for a single day, and not for any other period. A single day means the period from the close of regular trading on one trading day to the close on the next trading day. The Fund will enter into one or more swap agreements with financial institutions for a specified period, which may range from one day to longer than a year. Through each swap agreement, the Fund and the financial institution will agree to exchange the return (or differentials in rates of return) earned or realized on the Underlying Securitys share price. The gross return (meaning the return before deducting any fees or expenses) to be exchanged or swapped between the parties is calculated with respect to a notional amount, (meaning the face amount of the instrument) e.g., the return on or change in value of a particular dollar amount representing the Underlying Security. In the event the Fund is unable to achieve sufficient swap exposure, the Fund may not always achieve investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Underlying Security, and may return substantially less during such periods.

Defiance Daily Target 2X Long SMCI ETF

News

General

TEAM

Williams Racing And Atlassian Enter Into Title Partnership To Form Atlassian Williams Racing

Wells Fargo analyst Joseph O'Dea maintains Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) with a Overweight and raises the price target from $315 to $337.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Rockwell Automation, Raises Price Target to $337

EON Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EONR#NYSE">EONR</a>) ("EON" or the "Company") announced it has entered into an agreement with Pogo Royalty, LLC ("Pogo" or "Seller") that would result in a restructure of EON's balance sheet through (a) the retirement of a promissory note to Seller having an original principal amount of $15,000,000, (b) the purchase of a 10% Overriding Royalty Interest ("ORRI") in the Company's oil field property from Seller and (c) the repurchase of 100% of preferred units held by Seller in EON's subsidiary which would otherwise convert into the Company's Class A common stock on November 15, 2025 pursuant to a formula. The total consideration payable to Pogo in connection with the restructuring consists of $22,000,000 in cash from EON plus the issuance of 3,000,000 shares of the Company's Class A common stock to the Seller.
The agreement is subject to various closing conditions, including, without limitation, that the Company obtain adequate financing to fund the cash consideration portion, and that the agreement shall terminate if the closing does not take place within 120 days. The agreement also contains mutual general releases, which shall be effective upon the closing of the agreement.
The effect on the Company's balance sheet and financial position exclusive of the final financing arrangements the secure the $22 million in cash consideration is anticipated to include the following:
A reduction of liabilities comprised of principal and accrued interest debt owing to Seller of approximately $18,000,000
Reduction of $24,000,000 of redemption value of the currently outstanding preferred units held by Seller.
The ORRI which is valued at $14 million and is presently generating approximately $200,000 per month in proceeds.
The elimination of outstanding shares of the Company's Class B common stock.

EONR

EON Resources Moves to Restructure Balance Sheet With $22M Deal to Retire Debt and Reclaim Oil Royalties

Northland Capital Markets analyst Greg Gibas maintains PowerFleet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIOT#NASDAQ">AIOT</a>) with a Outperform and raises the price target from $10 to $11.

AIOT

Northland Capital Markets Maintains Outperform on PowerFleet, Raises Price Target to $11

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk said on Monday that the EV maker is &#8220;still on track&#8221; to launch <a href="https://www.benzinga.com/tech/25/01/43326143/tesla-stock-rises-5-after-hours-on-fsd-and-new-vehicle-promises-despite-q4-revenue-miss">autonomous ride-hailing in Austin, Texas</a> in June.
What Happened: Musk envisions deploying the company&#8217;s Model Y and Model 3 vehicles equipped with the company&#8217;s full self-driving driver assistance technology in Austin in June. While full self-driving currently requires active driver supervision, Musk and Tesla are optimistic that it can enable autonomous driving in time. 
&#8220;The threshold is achieving safety far in excess of the average human driver,&#8221; Musk said in a post on X.
The CEO on Monday also said that the company will roll out robotaxis to American cities beyond Austin before the end of the year. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">And it only gets better from here. Tesla is still on track to launch autonomous ride hailing in Austin in June and roll out to many cities in America by the end of this year. The threshold is achieving safety far in excess of the average human driver. Ultimately, autonomous… <a href="https://t.co/e81v28agSy">https://t.co/e81v28agSy</a>
&mdash; Harry Bōlz (@elonmusk) <a href="https://twitter.com/elonmusk/status/1889006561541882170?ref_src=twsrc%5Etfw">February 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;Autonomy will make the stalk about as useful as an appendix,&#8221; Musk said in another post on X. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Autonomy will make the stalk about as useful as an appendix
&mdash; Harry Bōlz (@elonmusk) <a href="https://twitter.com/elonmusk/status/1889008569263046714?ref_src=twsrc%5Etfw">February 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Tesla unveiled a<a href="https://www.benzinga.com/news/24/10/41284847/tesla-reveals-two-seater-cybercab-that-drives-itself"> Cybercab with no steering wheels or pedals</a> in October. The two-seat vehicle is meant for autonomous driving alone and is slated to start production in 2026 and join the company&#8217;s robotaxi fleet, which, until then, will be composed of the company&#8217;s Model 3 and Y vehicles.
Musk is currently banking big on autonomous driving to realize his vision for Tesla as an AI and robotics company and not merely a carmaker. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43617724/deploying-tesla-superchargers-cost-40000-45000-per-stall-or-roughly-the-price-of-model-3-sedan-says-exec">Deploying Tesla Superchargers Cost $40,000-$45,000 Per Stall Or Roughly The Price Of Model 3 Sedan, Says Exec</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

TSLA

Tesla 'Still On Track' To Launch Autonomous Ride Hailing In Austin By June, Says Elon Musk: '...It Only Gets Better From Here'

Entertainment

Sports

LTRY

Lottery.com's Brand Sports.com Inks Multi-Year Partnership Agreement With Soccerex

Wells Fargo analyst Larry Biegelsen maintains Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) with a Equal-Weight and lowers the price target from $198 to $195.

INSP

Wells Fargo Maintains Equal-Weight on Inspire Medical Systems, Lowers Price Target to $195

WIIM

AIFF

Firefly Neuroscience shares are trading higher after the company announced its acceptance into the NVIDIA Connect program.

NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares are trading lower in the premarket session on Tuesday despite a series of positive updates for the <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">electric vehicle maker.</a>
The company&#8217;s founder, chairman, and CEO, William Li, reportedly emphasized key strategic goals during an internal meeting as NIO prepares for 2025, <a target="_blank" href="https://cnevpost.com/2025/02/11/nio-ceo-highlights-importance-of-sales-volume-cost-reduction-in-internal-meeting/" rel="noreferrer noopener">reports </a>CnEV Post.
Li outlined three core visions for the company: doubling sales, achieving single-quarter profitability by the fourth quarter of 2025, and continuing to enhance systematic capabilities.
This meeting marked the company&#8217;s first quarterly gathering after celebrating its 10th anniversary.
Meanwhile, shares of other Chinese EV makers like XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) also fell on Tuesday.
The dip comes after Chinese EV giant&nbsp;BYD Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) launched smart driving features <a target="_blank" href="https://www.benzinga.com/tech/25/02/43617347/xpeng-geely-shares-fall-after-byd-launches-advanced-driver-assistance-features-on-car-priced-below-10000" rel="noreferrer noopener">on vehicles priced as low as&nbsp;$10,000.</a>
BYD on Monday rolled out an advanced driver-assist system called &#8220;God&#8217;s Eye&#8221; that it intends to install on a range of cars, including its low-cost Seagull hatchback priced under $10,000, for no added cost. The company began sales of 21 models equipped with the technology soon after the event.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/25/02/43614807/byd-teams-up-with-deepseek-to-outpace-tesla-in-budget-friendly-ai-driven-tech-for-chinese-cars-amid-regulatory-roadblocks" rel="noreferrer noopener">BYD Teams Up With DeepSeek To Outpace Tesla In Budget-Friendly AI-Driven Tech For Chinese Cars Amid Regulatory Roadblocks</a>
Meanwhile, NIO&#8217;s performance during the <a target="_blank" href="https://www.benzinga.com/25/02/43560265/whats-going-on-with-nio-stock-today" rel="noreferrer noopener">Chinese New Year holiday also stands out.</a> The company saw a surge in demand for its battery swap services, with 136,720 services recorded on February 3 alone.
This marked a peak in demand following a strong performance on January 25, with 119,848 services in a single day.
Additionally, NIO reported a 37.9% year-over-year increase in vehicle deliveries for January 2025, reaching 13,863 units.
Adding to the optimism, NIO is expected to be included in a major Hong Kong stock index after the Hang Seng Indexes Company Limited&#8217;s semi-annual review on February 21. This potential inclusion could attract passive investment inflows, providing a boost to the company&#8217;s stock price when the changes take effect on March 10.
Price Action: NIO shares are trading lower by 2.19% to $4.235 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43608052/traders-rethink-interest-rate-path-as-inflation-concerns-resume-feds-rate-cutting-cycle-is-over-economist-says" target="_blank" rel="noreferrer noopener">Traders Rethink Interest-Rate Path As Inflation Concerns Resume: &#8216;Fed&#8217;s Rate-Cutting Cycle Is Over,&#8217; Economist Says</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Equities

Markets

Movers

Media

BYDDY

XPEV

What's Going On With Chinese EV Maker NIO Stock On Tuesday?

Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced a positive update from an ongoing study evaluating the pharmacokinetics, safety and tolerability of its novel SP-26 ketamine extended-release rods when implanted subcutaneously. The SP-26 implant is a novel self-administered, non-opioid therapeutic intended for the treatment of chronic pain and fibromyalgia.
The launch of our non-GLP study in December 2024 marked the first small animal testing of SP-26, a key preclinical milestone. Implantation (dosing) was completed in the first week of January 2025 and no animals experienced serious side effects or discomfort. Absorption, distribution, metabolism, and excretion (ADME) testing is nearing completion and final safety, and pharmacokinetic reports are expected in March 2025.

SILO

Silo Pharma's SP-26 Implant Shows Early Results in Chronic Pain and Fibromyalgia Study

Wells Fargo analyst Michael Berg maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Overweight and raises the price target from $340 to $380.

MNDY

Wells Fargo Maintains Overweight on Monday.Com, Raises Price Target to $380

NVDA

Firefly Neuroscience Gains Acceptance Into NVIDIA Connect Program

Insurance

SPNS

Sapiens Launches Sapiens UnderwritingPro v14 Underwriting Solution For Life & Annuities Insurers

Wells Fargo analyst Chris Carey maintains Edgewell Personal Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>) with a Overweight and lowers the price target from $37 to $35.

Wells Fargo Maintains Overweight on Edgewell Personal Care, Lowers Price Target to $35

On Monday, Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) disclosed that it will launch a satellite for BlackSky Technology Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>) on a dedicated Electron mission, the first of multiple planned launches under a bulk order with <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43609169/rocket-lab-schedules-launch-for-first-of-multiple-missions-for-blacksky" rel="noreferrer noopener">the space-based intelligence company</a>.
The &#8220;Fasten Your Space Belts&#8221; mission will launch from Rocket Lab Launch Complex 1 in New Zealand, with a launch window opening on February 18 UTC.
The company will deploy BlackSky's first Gen-3 Earth-imaging satellite into a 470km circular orbit.
This marks Rocket Lab's ninth launch for BlackSky since 2019. The mission will bring Rocket Lab&#8217;s total deployed satellites to 210 and followed a record 16 successful launches in 2024.
Each BlackSky mission includes a Rocket Lab Motorized Lightband separation system, showcasing the company&#8217;s vertical integration and capability to deliver launch, satellite, and spacecraft component solutions.
&#8220;Fasten Your Space Belts&#8221; marks Rocket Lab&#8217;s second mission of 2025 and its 60th Electron launch. The 2025 manifest includes Electron missions for commercial and government customers, along with HASTE missions from Launch Complex 2, with launch windows to be announced later.
Rocket Lab founder and CEO, Sir Peter Beck said, &#8220;Electron is a trusted and reliable constellation builder for companies like BlackSky, allowing them to be in control of how, when, and where to deploy their constellation.&#8221;
&#8221;BlackSky is one of our earliest and longest-standing commercial satellite customers, and it&#8217;s great to be heading back to the pad with them once again to continue to advance and expand their constellation.&#8221;
Also, over the weekend, the company successfully&nbsp;completed its 59th Electron mission. The mission saw the deployment of five satellites into Low Earth Orbit for&nbsp;Kinéis, <a target="_blank" href="https://www.benzinga.com/25/02/43602341/rocket-labs-iot-constellation-for-kineis-takes-off" rel="noreferrer noopener">a French Internet-of-Things operator</a>.
Investors can gain exposure to the stock via&nbsp;ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) and Procure Space ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFO#NASDAQ">UFO</a>).
Price Action: RKLB shares are trading lower by 1.96% at $30.00 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43577796/cathie-woods-ark-invest-bets-big-on-amazon-roblox-and-illumina-while-trimming-palantir-stake-after-alex-karp-led-company-touched-an-all-time-high-on-thursday" target="_blank" rel="noreferrer noopener">Cathie Wood&#8217;s Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday</a></li>
</ul>

Large Cap

Contracts

ARKX

BlackSky Technology Inc. Class A Common Stock

BKSY

RKLB

Rocket Lab Gears Up For BlackSky's Gen-3 Satellite Launch: Details

Morgan Stanley analyst Joseph Moore maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Underweight and lowers the price target from $52 to $44.

Morgan Stanley Maintains Underweight on ON Semiconductor, Lowers Price Target to $44

Wells Fargo analyst Jason Haas maintains FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Equal-Weight and lowers the price target from $503 to $500.

Wells Fargo Maintains Equal-Weight on FactSet Research Systems, Lowers Price Target to $500

ESSA Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPIX#NASDAQ">EPIX</a>) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 35.71 percent decrease over losses of $(0.14) per share from the same period last year.

Earnings

Earnings Misses

EPIX

ESSA Pharma Q1 2025 GAAP EPS $(0.19) Misses $(0.12) Estimate, Cash $120.6M

Morgan Stanley analyst Kallum Titchmarsh maintains Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) with a Overweight and lowers the price target from $230 to $220.

Comments

Defiance Daily Target 2X Long SMCI ETF

空売り

Defiance Daily Target 2X Long SMCI ETF (NASDAQ:SMCX), 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル